Inter‐laboratory analytical improvement of succinylacetone and nitisinone quantification from dried blood spot samples

BACKGROUND: Nitisinone is used to treat hereditary tyrosinemia type 1 (HT‐1) by preventing accumulation of toxic metabolites, including succinylacetone (SA). Accurate quantification of SA during newborn screening is essential, as is quantification of both SA and nitisinone for disease monitoring and...

Descripción completa

Detalles Bibliográficos
Autores principales: Laeremans, Hilde, Turner, Charles, Andersson, Tommy, de Juan, Jose Angel Cocho, Gerrard, Adam, Heiner‐Fokkema, M. Rebecca, Herebian, Diran, Janzen, Nils, la Marca, Giancarlo, Rudebeck, Mattias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203657/
https://www.ncbi.nlm.nih.gov/pubmed/32395414
http://dx.doi.org/10.1002/jmd2.12112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203657/
https://www.ncbi.nlm.nih.gov/pubmed/32395414
http://dx.doi.org/10.1002/jmd2.12112

Ejemplares similares